Resverlogix Corp. - Asset Resilience Ratio

Latest as of June 2009: 0.00%

Resverlogix Corp. (RVX) has an Asset Resilience Ratio of 0.00% as of June 2009. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Resverlogix Corp. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CA$189.49

≈ $137.07 USD Cash + Short-term Investments

Total Assets

CA$15.53 Million

≈ $11.23 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2008)

This chart shows how Resverlogix Corp.'s Asset Resilience Ratio has changed over time. See Resverlogix Corp. balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Resverlogix Corp.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see RVX market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$189.49	0.0%
Total Liquid Assets	CA$189.49	0.00%

Asset Resilience Insights

Limited Liquidity: Resverlogix Corp. maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Resverlogix Corp. Industry Peers by Asset Resilience Ratio

Compare Resverlogix Corp.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	84.34%
3SBio Inc F:83B	Biotechnology	10.64%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Jiangxi Fushine Pharmaceutical Co Ltd SHE:300497	Biotechnology	0.02%
Novavax Inc NASDAQ:NVAX	Biotechnology	53.87%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Resverlogix Corp. (2003–2008)

The table below shows the annual Asset Resilience Ratio data for Resverlogix Corp..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2008-12-31	0.00%	CA$170.88 ≈ $123.61	CA$18.91 Million ≈ $13.68 Million	-74.97pp
2007-12-31	74.97%	CA$15.53 Million ≈ $11.23 Million	CA$20.71 Million ≈ $14.98 Million	+1.62pp
2006-12-31	73.34%	CA$11.00 Million ≈ $7.96 Million	CA$15.00 Million ≈ $10.85 Million	+21.87pp
2005-12-31	51.47%	CA$4.15 Million ≈ $3.00 Million	CA$8.06 Million ≈ $5.83 Million	+22.88pp
2004-12-31	28.60%	CA$2.92 Million ≈ $2.11 Million	CA$10.20 Million ≈ $7.38 Million	-49.39pp
2003-12-31	77.99%	CA$2.10 Million ≈ $1.52 Million	CA$2.69 Million ≈ $1.95 Million	--

pp = percentage points

About Resverlogix Corp.

TO:RVX Canada Biotechnology

Market Cap

$22.93 Million

CA$31.70 Million CAD

Market Cap Rank

#24679 Global

#950 in Canada

Share Price

CA$0.10

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$0.23

All Time High

CA$4.79